SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-277889
Filing Date
2023-11-15
Accepted
2023-11-15 16:07:30
Documents
12
Period of Report
2023-11-14
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d850440d8k.htm   iXBRL 8-K 28296
  Complete submission text file 0001193125-23-277889.txt   151781

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bxrx-20231114.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxrx-20231114_lab.xml EX-101.LAB 17979
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxrx-20231114_pre.xml EX-101.PRE 11263
6 EXTRACTED XBRL INSTANCE DOCUMENT d850440d8k_htm.xml XML 3368
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39101 | Film No.: 231410620
SIC: 2834 Pharmaceutical Preparations